25 XP   0   0   10

Jiangsu Nhwa Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse Jiangsu Nhwa Pharmaceutical Co Ltd together

PenkeI guess you are interested in Jiangsu Nhwa Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Jiangsu Nhwa Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Jiangsu Nhwa Pharmaceutical Co Ltd

I send you an email if I find something interesting about Jiangsu Nhwa Pharmaceutical Co Ltd.

Quick analysis of Jiangsu Nhwa Pharmaceutical Co Ltd (30 sec.)










What can you expect buying and holding a share of Jiangsu Nhwa Pharmaceutical Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.00
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥6.22
Expected worth in 1 year
¥7.04
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
¥0.83
Return On Investment
3.8%

For what price can you sell your share?

Current Price per Share
¥21.62
Expected price per share
¥15.97 - ¥23.70
How sure are you?
50%

1. Valuation of Jiangsu Nhwa Pharmaceutical Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥21.62

Intrinsic Value Per Share

¥6.76 - ¥16.05

Total Value Per Share

¥12.98 - ¥22.26

2. Growth of Jiangsu Nhwa Pharmaceutical Co Ltd (5 min.)




Is Jiangsu Nhwa Pharmaceutical Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$867.3m$711.9m$104.1m12.8%

How much money is Jiangsu Nhwa Pharmaceutical Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$36.1m$29.9m$6.1m17.0%
Net Profit Margin21.5%20.7%--

How much money comes from the company's main activities?

3. Financial Health of Jiangsu Nhwa Pharmaceutical Co Ltd (5 min.)




What can you expect buying and holding a share of Jiangsu Nhwa Pharmaceutical Co Ltd? (5 min.)

Welcome investor! Jiangsu Nhwa Pharmaceutical Co Ltd's management wants to use your money to grow the business. In return you get a share of Jiangsu Nhwa Pharmaceutical Co Ltd.

What can you expect buying and holding a share of Jiangsu Nhwa Pharmaceutical Co Ltd?

First you should know what it really means to hold a share of Jiangsu Nhwa Pharmaceutical Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Jiangsu Nhwa Pharmaceutical Co Ltd is ¥21.62. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Jiangsu Nhwa Pharmaceutical Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Jiangsu Nhwa Pharmaceutical Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥6.22. Based on the TTM, the Book Value Change Per Share is ¥0.21 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.17 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Jiangsu Nhwa Pharmaceutical Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.050.2%0.040.2%0.030.1%0.030.1%0.020.1%
Usd Book Value Change Per Share0.050.2%0.030.1%0.020.1%0.020.1%0.020.1%
Usd Dividend Per Share0.000.0%0.000.0%0.020.1%0.010.0%0.010.0%
Usd Total Gains Per Share0.050.2%0.030.1%0.040.2%0.030.1%0.020.1%
Usd Price Per Share3.67-3.75-1.99-2.24-2.65-
Price to Earnings Ratio19.59-27.61-18.73-20.90-54.54-
Price-to-Total Gains Ratio78.31-155.71-46.14-147.32-197.69-
Price to Book Ratio4.26-4.63-2.81-3.60-9.36-
Price-to-Total Gains Ratio78.31-155.71-46.14-147.32-197.69-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.992208
Number of shares334
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.01
Usd Book Value Change Per Share0.030.02
Usd Total Gains Per Share0.030.03
Gains per Quarter (334 shares)9.5810.15
Gains per Year (334 shares)38.3140.61
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10382893131
217666186372
311141042794113
4115214237126154
5119018046157195
6222821855189236
7226625664220277
8230429473252318
9334233282283359
10338037092315400

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%61.00.00.0100.0%
Book Value Change Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%61.00.00.0100.0%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%55.00.06.090.2%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%61.00.00.0100.0%

Fundamentals of Jiangsu Nhwa Pharmaceutical Co Ltd

About Jiangsu Nhwa Pharmaceutical Co Ltd

Jiangsu Nhwa Pharmaceutical Co., LTD engages in research and development, production, marketing, and services related to central nervous system drugs in China and internationally. The company's products are used for treatment of anesthesia, analgesia, mental and neurological diseases, narcotic, psychiatry, and neurological categories, as well as APIs. It sells its products through hospitals, private hospitals, online pharmacies, and chain pharmacies. The company was founded in 1978 and is headquartered in Xuzhou, China.

Fundamental data was last updated by Penke on 2024-03-24 00:08:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Jiangsu Nhwa Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Jiangsu Nhwa Pharmaceutical Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Jiangsu Nhwa Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 27.2% means that ¥0.27 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Jiangsu Nhwa Pharmaceutical Co Ltd:

  • The MRQ is 27.2%. The company is making a huge profit. +2
  • The TTM is 21.5%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ27.2%TTM21.5%+5.7%
TTM21.5%YOY20.7%+0.7%
TTM21.5%5Y20.0%+1.5%
5Y20.0%10Y15.3%+4.8%
1.1.2. Return on Assets

Shows how efficient Jiangsu Nhwa Pharmaceutical Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Jiangsu Nhwa Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 4.8% Return on Assets means that Jiangsu Nhwa Pharmaceutical Co Ltd generated ¥0.05 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Jiangsu Nhwa Pharmaceutical Co Ltd:

  • The MRQ is 4.8%. Using its assets, the company is less efficient in making profit.
  • The TTM is 3.8%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ4.8%TTM3.8%+1.0%
TTM3.8%YOY3.6%+0.2%
TTM3.8%5Y3.8%0.0%
5Y3.8%10Y3.4%+0.4%
1.1.3. Return on Equity

Shows how efficient Jiangsu Nhwa Pharmaceutical Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Jiangsu Nhwa Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 5.4% Return on Equity means Jiangsu Nhwa Pharmaceutical Co Ltd generated ¥0.05 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Jiangsu Nhwa Pharmaceutical Co Ltd:

  • The MRQ is 5.4%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 4.4%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ5.4%TTM4.4%+1.0%
TTM4.4%YOY4.2%+0.2%
TTM4.4%5Y4.5%-0.2%
5Y4.5%10Y4.6%0.0%

1.2. Operating Efficiency of Jiangsu Nhwa Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Jiangsu Nhwa Pharmaceutical Co Ltd is operating .

  • Measures how much profit Jiangsu Nhwa Pharmaceutical Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Jiangsu Nhwa Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 29.8% means the company generated ¥0.30  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Jiangsu Nhwa Pharmaceutical Co Ltd:

  • The MRQ is 29.8%. The company is operating very efficient. +2
  • The TTM is 15.8%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ29.8%TTM15.8%+14.0%
TTM15.8%YOY21.3%-5.5%
TTM15.8%5Y20.4%-4.6%
5Y20.4%10Y10.7%+9.7%
1.2.2. Operating Ratio

Measures how efficient Jiangsu Nhwa Pharmaceutical Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.99 means that the operating costs are ¥0.99 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Jiangsu Nhwa Pharmaceutical Co Ltd:

  • The MRQ is 0.990. The company is less efficient in keeping operating costs low.
  • The TTM is 1.030. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ0.990TTM1.030-0.040
TTM1.030YOY0.993+0.038
TTM1.0305Y1.055-0.025
5Y1.05510Y0.814+0.241

1.3. Liquidity of Jiangsu Nhwa Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Jiangsu Nhwa Pharmaceutical Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 6.52 means the company has ¥6.52 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Jiangsu Nhwa Pharmaceutical Co Ltd:

  • The MRQ is 6.516. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.963. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ6.516TTM5.963+0.553
TTM5.963YOY5.916+0.047
TTM5.9635Y5.538+0.425
5Y5.53810Y2.841+2.697
1.3.2. Quick Ratio

Measures if Jiangsu Nhwa Pharmaceutical Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Jiangsu Nhwa Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 2.97 means the company can pay off ¥2.97 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Jiangsu Nhwa Pharmaceutical Co Ltd:

  • The MRQ is 2.970. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.816. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.970TTM2.816+0.154
TTM2.816YOY2.569+0.247
TTM2.8165Y2.233+0.583
5Y2.23310Y1.570+0.662

1.4. Solvency of Jiangsu Nhwa Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Jiangsu Nhwa Pharmaceutical Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Jiangsu Nhwa Pharmaceutical Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.12 means that Jiangsu Nhwa Pharmaceutical Co Ltd assets are financed with 12.2% credit (debt) and the remaining percentage (100% - 12.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Jiangsu Nhwa Pharmaceutical Co Ltd:

  • The MRQ is 0.122. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.135. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.122TTM0.135-0.013
TTM0.135YOY0.140-0.005
TTM0.1355Y0.160-0.025
5Y0.16010Y0.249-0.089
1.4.2. Debt to Equity Ratio

Measures if Jiangsu Nhwa Pharmaceutical Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Jiangsu Nhwa Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 13.8% means that company has ¥0.14 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Jiangsu Nhwa Pharmaceutical Co Ltd:

  • The MRQ is 0.138. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.155. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.138TTM0.155-0.017
TTM0.155YOY0.163-0.008
TTM0.1555Y0.194-0.039
5Y0.19410Y0.368-0.174

2. Market Valuation of Jiangsu Nhwa Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Jiangsu Nhwa Pharmaceutical Co Ltd generates.

  • Above 15 is considered overpriced but always compare Jiangsu Nhwa Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 19.59 means the investor is paying ¥19.59 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Jiangsu Nhwa Pharmaceutical Co Ltd:

  • The EOD is 15.974. Based on the earnings, the company is fair priced.
  • The MRQ is 19.587. Based on the earnings, the company is fair priced.
  • The TTM is 27.608. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD15.974MRQ19.587-3.613
MRQ19.587TTM27.608-8.021
TTM27.608YOY18.726+8.882
TTM27.6085Y20.902+6.706
5Y20.90210Y54.545-33.643
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Jiangsu Nhwa Pharmaceutical Co Ltd:

  • The EOD is 18.232. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 22.355. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 119.961. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD18.232MRQ22.355-4.124
MRQ22.355TTM119.961-97.606
TTM119.961YOY38.165+81.796
TTM119.9615Y56.616+63.345
5Y56.61610Y2.101+54.515
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Jiangsu Nhwa Pharmaceutical Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Jiangsu Nhwa Pharmaceutical Co Ltd:

  • The EOD is 3.476. Based on the equity, the company is fair priced.
  • The MRQ is 4.262. Based on the equity, the company is fair priced.
  • The TTM is 4.625. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD3.476MRQ4.262-0.786
MRQ4.262TTM4.625-0.363
TTM4.625YOY2.813+1.813
TTM4.6255Y3.602+1.023
5Y3.60210Y9.358-5.756
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Jiangsu Nhwa Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.3360.206+64%0.169+99%0.170+98%0.135+148%
Book Value Per Share--6.2195.853+6%5.106+22%4.443+40%3.132+99%
Current Ratio--6.5165.963+9%5.916+10%5.538+18%2.841+129%
Debt To Asset Ratio--0.1220.135-10%0.140-13%0.160-23%0.249-51%
Debt To Equity Ratio--0.1380.155-11%0.163-15%0.194-29%0.368-62%
Dividend Per Share--0.0020.002+29%0.150-99%0.050-96%0.038-95%
Eps--0.3380.265+28%0.215+57%0.203+67%0.142+138%
Free Cash Flow Per Share--0.2960.178+66%0.129+129%0.142+109%0.088+237%
Free Cash Flow To Equity Per Share--0.2860.168+70%0.069+314%0.103+177%0.107+166%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--16.045--------
Intrinsic Value_10Y_min--6.762--------
Intrinsic Value_1Y_max--0.843--------
Intrinsic Value_1Y_min--0.410--------
Intrinsic Value_3Y_max--3.116--------
Intrinsic Value_3Y_min--1.470--------
Intrinsic Value_5Y_max--6.092--------
Intrinsic Value_5Y_min--2.785--------
Market Cap21784096145.920-23%26711211324.16027265385832.960-2%14456397754.560+85%16386691743.380+63%19326449780.078+38%
Net Profit Margin--0.2720.215+26%0.207+31%0.200+36%0.153+78%
Operating Margin--0.2980.158+89%0.213+40%0.204+46%0.107+179%
Operating Ratio--0.9901.030-4%0.9930%1.055-6%0.814+22%
Pb Ratio3.476-23%4.2624.625-8%2.813+52%3.602+18%9.358-54%
Pe Ratio15.974-23%19.58727.608-29%18.726+5%20.902-6%54.545-64%
Price Per Share21.620-23%26.51027.060-2%14.348+85%16.211+64%19.155+38%
Price To Free Cash Flow Ratio18.232-23%22.355119.961-81%38.165-41%56.616-61%2.101+964%
Price To Total Gains Ratio63.867-23%78.312155.709-50%46.143+70%147.321-47%197.692-60%
Quick Ratio--2.9702.816+5%2.569+16%2.233+33%1.570+89%
Return On Assets--0.0480.038+26%0.036+33%0.038+25%0.034+41%
Return On Equity--0.0540.044+24%0.042+30%0.045+20%0.046+19%
Total Gains Per Share--0.3390.207+63%0.320+6%0.220+54%0.173+95%
Usd Book Value--867304801.803816178908.640+6%711992384.652+22%621673833.478+40%437785899.845+98%
Usd Book Value Change Per Share--0.0470.028+64%0.023+99%0.024+98%0.019+148%
Usd Book Value Per Share--0.8610.810+6%0.707+22%0.615+40%0.433+99%
Usd Dividend Per Share--0.0000.000+29%0.021-99%0.007-96%0.005-95%
Usd Eps--0.0470.037+28%0.030+57%0.028+67%0.020+138%
Usd Free Cash Flow--41341886.99924867252.516+66%18025336.612+129%19863820.456+108%12287613.414+236%
Usd Free Cash Flow Per Share--0.0410.025+66%0.018+129%0.020+109%0.012+237%
Usd Free Cash Flow To Equity Per Share--0.0400.023+70%0.010+314%0.014+177%0.015+166%
Usd Market Cap3014918906.595-23%3696831647.2643773529399.282-2%2000765449.231+85%2267918137.284+63%2674780649.563+38%
Usd Price Per Share2.992-23%3.6693.745-2%1.986+85%2.244+64%2.651+38%
Usd Profit--47185859.81136146361.257+31%29989233.497+57%28227263.872+67%19783572.709+139%
Usd Revenue--173782844.018167269289.542+4%144068005.607+21%140960156.284+23%123016973.812+41%
Usd Total Gains Per Share--0.0470.029+63%0.044+6%0.030+54%0.024+95%
 EOD+4 -4MRQTTM+31 -4YOY+30 -55Y+30 -510Y+29 -6

3.2. Fundamental Score

Let's check the fundamental score of Jiangsu Nhwa Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1515.974
Price to Book Ratio (EOD)Between0-13.476
Net Profit Margin (MRQ)Greater than00.272
Operating Margin (MRQ)Greater than00.298
Quick Ratio (MRQ)Greater than12.970
Current Ratio (MRQ)Greater than16.516
Debt to Asset Ratio (MRQ)Less than10.122
Debt to Equity Ratio (MRQ)Less than10.138
Return on Equity (MRQ)Greater than0.150.054
Return on Assets (MRQ)Greater than0.050.048
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of Jiangsu Nhwa Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5035.815
Ma 20Greater thanMa 5022.673
Ma 50Greater thanMa 10024.032
Ma 100Greater thanMa 20025.171
OpenGreater thanClose21.700
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets7,139,165
Total Liabilities872,512
Total Stockholder Equity6,306,372
 As reported
Total Liabilities 872,512
Total Stockholder Equity+ 6,306,372
Total Assets = 7,139,165

Assets

Total Assets7,139,165
Total Current Assets5,163,192
Long-term Assets1,975,973
Total Current Assets
Cash And Cash Equivalents 2,066,307
Short-term Investments 1,327,300
Net Receivables 1,025,705
Inventory 681,073
Other Current Assets 62,807
Total Current Assets  (as reported)5,163,192
Total Current Assets  (calculated)5,163,192
+/- 0
Long-term Assets
Property Plant Equipment 1,292,395
Intangible Assets 266,366
Other Assets 375,119
Long-term Assets  (as reported)1,975,973
Long-term Assets  (calculated)1,933,881
+/- 42,092

Liabilities & Shareholders' Equity

Total Current Liabilities792,341
Long-term Liabilities80,171
Total Stockholder Equity6,306,372
Total Current Liabilities
Short Long Term Debt 30,000
Accounts payable 326,812
Other Current Liabilities 408,095
Total Current Liabilities  (as reported)792,341
Total Current Liabilities  (calculated)764,907
+/- 27,434
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt21,636
Other Liabilities 58,305
Long-term Liabilities  (as reported)80,171
Long-term Liabilities  (calculated)79,941
+/- 230
Total Stockholder Equity
Common Stock1,007,588
Retained Earnings 5,166,271
Other Stockholders Equity 13,103
Total Stockholder Equity (as reported)6,306,372
Total Stockholder Equity (calculated)6,186,962
+/- 119,410
Other
Capital Stock1,007,588
Common Stock Shares Outstanding 1,007,588
Net Invested Capital 6,336,602
Net Tangible Assets 6,111,537
Net Working Capital 4,370,852
Property Plant and Equipment Gross 1,292,395



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302007-12-312006-12-312005-12-31
> Total Assets 
482,862
504,303
596,776
632,501
773,998
729,405
805,603
844,983
864,370
780,684
882,214
894,313
922,581
954,298
1,017,428
1,057,675
1,122,076
1,093,598
1,157,614
1,235,921
1,344,920
1,344,849
1,488,559
1,474,137
1,550,554
1,566,341
1,654,608
1,760,005
1,875,312
1,922,656
2,084,831
2,661,815
2,609,461
2,550,922
2,683,964
2,753,476
2,882,404
2,974,890
3,187,533
3,150,460
3,319,851
3,301,570
3,449,147
3,635,272
3,910,280
4,030,165
4,263,302
4,288,751
4,542,601
4,201,502
4,414,687
4,431,776
4,644,859
4,748,440
5,014,949
5,087,872
5,437,324
5,697,187
6,046,413
5,946,351
6,245,592
6,481,746
6,815,269
6,830,643
7,139,165
7,139,1656,830,6436,815,2696,481,7466,245,5925,946,3516,046,4135,697,1875,437,3245,087,8725,014,9494,748,4404,644,8594,431,7764,414,6874,201,5024,542,6014,288,7514,263,3024,030,1653,910,2803,635,2723,449,1473,301,5703,319,8513,150,4603,187,5332,974,8902,882,4042,753,4762,683,9642,550,9222,609,4612,661,8152,084,8311,922,6561,875,3121,760,0051,654,6081,566,3411,550,5541,474,1371,488,5591,344,8491,344,9201,235,9211,157,6141,093,5981,122,0761,057,6751,017,428954,298922,581894,313882,214780,684864,370844,983805,603729,405773,998632,501596,776504,303482,862
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,795,895
2,911,489
3,134,021
3,142,353
3,378,562
3,003,446
3,196,805
3,152,554
3,315,000
3,319,580
3,529,759
3,546,141
3,816,814
4,043,183
4,351,847
4,228,538
4,456,408
4,650,403
4,934,555
4,884,439
5,163,192
5,163,1924,884,4394,934,5554,650,4034,456,4084,228,5384,351,8474,043,1833,816,8143,546,1413,529,7593,319,5803,315,0003,152,5543,196,8053,003,4463,378,5623,142,3533,134,0212,911,4892,795,89500000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,015,647
971,854
1,024,267
980,481
1,199,855
1,820,807
2,033,983
1,872,302
2,040,832
1,402,422
1,322,783
1,172,617
1,303,227
1,607,591
1,789,068
1,718,374
1,803,965
1,532,214
1,519,602
1,951,247
2,066,307
2,066,3071,951,2471,519,6021,532,2141,803,9651,718,3741,789,0681,607,5911,303,2271,172,6171,322,7831,402,4222,040,8321,872,3022,033,9831,820,8071,199,855980,4811,024,267971,8541,015,64700000000000000000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
505,000
0
655,000
0
70,000
90,000
115,000
145,000
837,000
1,118,000
1,193,000
1,226,000
1,058,400
1,085,000
1,000,900
1,053,200
1,452,000
1,761,000
1,130,000
1,327,300
1,327,3001,130,0001,761,0001,452,0001,053,2001,000,9001,085,0001,058,4001,226,0001,193,0001,118,000837,000145,000115,00090,00070,0000655,0000505,000000000000000000000000000000000000000000000000
       Net Receivables 
181,967
125,418
170,695
190,053
191,435
171,347
177,955
222,178
243,063
182,361
242,344
267,011
297,906
268,075
316,110
324,469
355,840
307,678
369,984
430,613
498,701
408,040
538,047
536,039
542,808
489,451
536,251
597,327
633,285
589,695
686,542
718,677
785,254
644,806
754,542
793,705
845,093
764,775
861,714
837,645
808,884
729,638
809,083
883,270
987,342
951,090
874,628
930,433
963,031
622,838
604,441
654,061
606,986
628,566
567,250
690,108
728,420
748,094
790,090
806,026
870,167
873,863
792,660
930,548
1,025,705
1,025,705930,548792,660873,863870,167806,026790,090748,094728,420690,108567,250628,566606,986654,061604,441622,838963,031930,433874,628951,090987,342883,270809,083729,638808,884837,645861,714764,775845,093793,705754,542644,806785,254718,677686,542589,695633,285597,327536,251489,451542,808536,039538,047408,040498,701430,613369,984307,678355,840324,469316,110268,075297,906267,011242,344182,361243,063222,178177,955171,347191,435190,053170,695125,418181,967
       Other Current Assets 
17,901
29,271
10,585
7,135
15,138
21,722
21,199
16,490
23,815
20,313
19,649
18,984
15,562
28,121
30,824
33,775
40,661
51,035
39,964
66,469
58,254
66,245
69,396
53,803
55,186
44,839
48,515
56,909
54,022
27,496
30,505
39,710
25,523
33,441
53,385
46,830
69,194
76,008
187,324
53,472
214,791
40,495
380,422
46,457
406,623
73,042
635,924
655,387
656,600
54,317
73,189
29,948
93,294
17,733
14,943
18,735
28,477
19,959
47,031
31,228
34,126
75,986
52,780
6,735
62,807
62,8076,73552,78075,98634,12631,22847,03119,95928,47718,73514,94317,73393,29429,94873,18954,317656,600655,387635,92473,042406,62346,457380,42240,495214,79153,472187,32476,00869,19446,83053,38533,44125,52339,71030,50527,49654,02256,90948,51544,83955,18653,80369,39666,24558,25466,46939,96451,03540,66133,77530,82428,12115,56218,98419,64920,31323,81516,49021,19921,72215,1387,13510,58529,27117,901
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,129,280
1,146,398
1,164,039
1,198,056
1,217,882
1,279,222
1,329,858
1,428,860
1,485,190
1,541,731
1,620,510
1,654,003
1,694,566
1,717,813
1,789,184
1,831,342
1,880,714
1,946,204
1,975,973
1,975,9731,946,2041,880,7141,831,3421,789,1841,717,8131,694,5661,654,0031,620,5101,541,7311,485,1901,428,8601,329,8581,279,2221,217,8821,198,0561,164,0391,146,3981,129,2800000000000000000000000000000000000000000000000
       Property Plant Equipment 
119,331
137,653
196,204
164,042
156,558
184,561
150,035
190,347
154,533
198,234
175,553
234,616
216,738
270,235
239,488
272,891
250,754
289,872
259,238
308,322
279,573
322,682
278,499
345,174
290,816
386,175
349,556
403,685
470,709
532,331
583,166
619,784
649,788
685,690
707,549
713,505
725,071
730,181
739,585
747,899
766,705
798,387
854,110
869,048
880,035
843,045
857,568
887,495
899,835
898,958
896,768
916,855
947,313
1,034,257
1,069,832
1,134,090
1,154,592
1,158,346
1,178,392
1,195,497
1,232,056
1,303,701
1,296,327
1,289,008
1,292,395
1,292,3951,289,0081,296,3271,303,7011,232,0561,195,4971,178,3921,158,3461,154,5921,134,0901,069,8321,034,257947,313916,855896,768898,958899,835887,495857,568843,045880,035869,048854,110798,387766,705747,899739,585730,181725,071713,505707,549685,690649,788619,784583,166532,331470,709403,685349,556386,175290,816345,174278,499322,682279,573308,322259,238289,872250,754272,891239,488270,235216,738234,616175,553198,234154,533190,347150,035184,561156,558164,042196,204137,653119,331
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
44,090
45,056
43,000
40,966
41,470
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000041,47040,96643,00045,05644,09000000000000000000000000000000000000000000000
       Intangible Assets 
26,965
37,730
4,371
39,726
39,054
2,288
37,586
1,556
36,543
897
35,683
522
34,960
221
34,334
6
33,879
153
33,652
299
33,422
326
49,006
286
66,042
259
65,151
64,718
83,939
82,589
81,559
80,531
79,502
81,804
80,753
79,712
79,074
78,058
77,232
76,223
66,612
66,722
66,116
65,260
64,241
110,962
109,702
8,295
107,086
106,191
104,853
103,483
102,129
121,863
120,594
119,229
137,759
167,498
171,421
182,995
197,290
223,752
232,018
264,337
266,366
266,366264,337232,018223,752197,290182,995171,421167,498137,759119,229120,594121,863102,129103,483104,853106,191107,0868,295109,702110,96264,24165,26066,11666,72266,61276,22377,23278,05879,07479,71280,75381,80479,50280,53181,55982,58983,93964,71865,15125966,04228649,00632633,42229933,65215333,879634,33422134,96052235,68389736,5431,55637,5862,28839,05439,7264,37137,73026,965
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
71,750
66,617
75,033
76,477
94,680
106,296
1,078,207
1,150,811
119,258
122,223
119,635
103,848
112,675
121,932
146,952
75,882
104,595
130,933
156,431
156,431130,933104,59575,882146,952121,932112,675103,848119,635122,223119,2581,150,8111,078,207106,29694,68076,47775,03366,61771,7500000000000000000000000000000000000000000000000
> Total Liabilities 
357,125
381,635
444,391
459,436
439,840
385,659
451,173
484,624
488,447
384,681
469,767
465,653
472,517
491,743
533,374
549,975
585,023
537,585
572,274
615,544
685,525
662,407
768,493
713,007
743,066
730,133
770,828
818,969
856,530
863,612
966,307
944,785
823,733
723,603
787,636
775,631
810,989
850,974
984,118
865,390
902,487
840,244
889,202
967,592
1,071,578
1,074,670
1,173,024
1,053,902
1,080,466
596,679
669,521
542,194
508,668
642,943
741,933
669,918
681,851
793,454
955,939
800,811
807,525
896,989
1,005,339
902,996
872,512
872,512902,9961,005,339896,989807,525800,811955,939793,454681,851669,918741,933642,943508,668542,194669,521596,6791,080,4661,053,9021,173,0241,074,6701,071,578967,592889,202840,244902,487865,390984,118850,974810,989775,631787,636723,603823,733944,785966,307863,612856,530818,969770,828730,133743,066713,007768,493662,407685,525615,544572,274537,585585,023549,975533,374491,743472,517465,653469,767384,681488,447484,624451,173385,659439,840459,436444,391381,635357,125
   > Total Current Liabilities 
352,694
377,205
439,960
459,206
439,610
385,429
450,943
484,394
488,218
375,406
460,492
456,378
463,242
481,581
523,212
539,813
574,861
527,275
561,965
605,234
675,355
635,963
743,166
686,848
716,907
702,347
743,042
791,183
828,744
829,263
931,957
910,436
789,384
688,999
753,032
741,026
776,384
815,897
949,611
830,883
806,042
742,079
790,537
868,926
972,912
983,621
1,081,975
962,853
989,418
515,915
588,857
461,330
427,804
574,945
634,126
537,393
550,359
681,957
834,877
690,291
696,432
793,943
906,093
809,497
792,341
792,341809,497906,093793,943696,432690,291834,877681,957550,359537,393634,126574,945427,804461,330588,857515,915989,418962,8531,081,975983,621972,912868,926790,537742,079806,042830,883949,611815,897776,384741,026753,032688,999789,384910,436931,957829,263828,744791,183743,042702,347716,907686,848743,166635,963675,355605,234561,965527,275574,861539,813523,212481,581463,242456,378460,492375,406488,218484,394450,943385,429439,610459,206439,960377,205352,694
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
363,380
367,850
367,850
38,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000038,000367,850367,850363,3800000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
363,380
367,850
367,850
38,000
38,000
38,000
38,000
38,000
33,000
38,000
38,000
38,000
30,000
35,000
30,000
30,000
45,000
30,000
30,000
30,00030,00045,00030,00030,00035,00030,00038,00038,00038,00033,00038,00038,00038,00038,00038,000367,850367,850363,3800000000000000000000000000000000000000000000000
       Accounts payable 
135,473
135,798
187,007
196,666
206,630
168,208
206,820
245,195
250,144
183,843
230,509
233,099
248,722
260,753
280,114
325,109
327,344
284,139
295,760
339,100
401,837
315,251
443,560
364,097
370,211
324,188
369,901
374,389
356,429
302,397
381,734
328,969
379,957
294,672
302,249
327,234
330,791
333,361
406,653
366,894
326,826
330,035
360,857
360,356
319,156
352,775
329,876
283,542
306,219
127,548
139,467
139,623
93,905
165,192
164,887
199,448
262,866
267,174
308,816
292,904
315,403
255,739
275,503
256,296
326,812
326,812256,296275,503255,739315,403292,904308,816267,174262,866199,448164,887165,19293,905139,623139,467127,548306,219283,542329,876352,775319,156360,356360,857330,035326,826366,894406,653333,361330,791327,234302,249294,672379,957328,969381,734302,397356,429374,389369,901324,188370,211364,097443,560315,251401,837339,100295,760284,139327,344325,109280,114260,753248,722233,099230,509183,843250,144245,195206,820168,208206,630196,666187,007135,798135,473
       Other Current Liabilities 
96,021
81,907
82,953
73,710
76,680
78,721
74,623
73,699
72,574
49,063
70,483
62,979
71,220
54,528
76,798
67,204
77,217
49,836
72,905
50,834
63,218
73,412
84,306
59,951
87,696
99,159
142,141
134,794
155,314
154,866
198,223
163,966
166,427
156,327
203,783
169,793
209,593
219,536
278,788
209,818
217,046
179,873
198,881
186,771
291,400
288,616
388,139
281,042
314,780
323,919
410,808
250,003
295,690
333,026
435,731
253,646
248,982
298,684
474,922
288,235
328,353
478,943
564,046
25,934
408,095
408,09525,934564,046478,943328,353288,235474,922298,684248,982253,646435,731333,026295,690250,003410,808323,919314,780281,042388,139288,616291,400186,771198,881179,873217,046209,818278,788219,536209,593169,793203,783156,327166,427163,966198,223154,866155,314134,794142,14199,15987,69659,95184,30673,41263,21850,83472,90549,83677,21767,20476,79854,52871,22062,97970,48349,06372,57473,69974,62378,72176,68073,71082,95381,90796,021
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
91,049
91,049
91,049
80,764
80,664
80,864
80,864
67,997
107,808
132,525
131,492
111,496
121,063
110,520
111,092
103,046
99,246
93,499
80,171
80,17193,49999,246103,046111,092110,520121,063111,496131,492132,525107,80867,99780,86480,86480,66480,76491,04991,04991,0490000000000000000000000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-363,380
-367,850
-367,850
-38,000
0
0
0
0
39,811
64,528
63,495
47,669
57,235
46,692
47,265
41,905
40,676
34,957
21,636
21,63634,95740,67641,90547,26546,69257,23547,66963,49564,52839,8110000-38,000-367,850-367,850-363,3800000000000000000000000000000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
230
230
230
230
230
230
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000002302302302302302300000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,724
3,660
3,607
3,268
3,150
3,826
3,512
4,876
5,382
25,951
25,981
27,475
49,736
80,509
85,762
97,962
113,446
131,878
159,424
0
116,024
116,0240159,424131,878113,44697,96285,76280,50949,73627,47525,98125,9515,3824,8763,5123,8263,1503,2683,6073,6603,72400000000000000000000000000000000000000000000
> Total Stockholder Equity
116,617
115,600
145,467
167,170
328,072
337,020
348,329
354,677
369,529
388,860
405,666
422,627
444,670
458,556
480,462
504,254
534,068
552,503
582,143
617,625
657,016
680,501
718,661
760,526
807,518
838,034
885,892
943,699
1,002,364
1,043,287
1,103,330
1,702,632
1,772,166
1,814,628
1,884,893
1,957,734
2,039,969
2,095,585
2,180,899
2,266,914
2,402,333
2,452,376
2,557,946
2,667,626
2,840,711
2,956,350
3,094,290
3,240,858
3,472,143
3,620,679
3,763,066
3,905,829
4,151,871
4,123,001
4,292,081
4,435,502
4,774,911
4,920,688
5,109,377
5,166,674
5,461,045
5,622,249
5,849,678
5,965,434
6,306,372
6,306,3725,965,4345,849,6785,622,2495,461,0455,166,6745,109,3774,920,6884,774,9114,435,5024,292,0814,123,0014,151,8713,905,8293,763,0663,620,6793,472,1433,240,8583,094,2902,956,3502,840,7112,667,6262,557,9462,452,3762,402,3332,266,9142,180,8992,095,5852,039,9691,957,7341,884,8931,814,6281,772,1661,702,6321,103,3301,043,2871,002,364943,699885,892838,034807,518760,526718,661680,501657,016617,625582,143552,503534,068504,254480,462458,556444,670422,627405,666388,860369,529354,677348,329337,020328,072167,170145,467115,600116,617
   Common Stock
63,900
63,900
90,000
90,000
120,000
120,000
120,000
180,000
180,000
180,000
180,000
234,000
234,000
234,000
234,000
234,000
234,000
234,000
234,000
234,000
234,000
234,000
234,000
327,600
327,600
327,600
327,600
393,120
393,120
393,120
393,120
485,167
485,167
485,167
485,167
630,717
630,717
630,717
630,717
1,009,147
1,009,147
1,009,147
1,009,147
1,009,147
1,020,016
1,020,016
1,020,016
1,019,602
1,019,388
1,019,388
1,019,388
1,019,126
1,019,095
1,007,663
1,007,663
1,007,588
1,007,588
1,007,588
1,007,588
1,007,588
1,007,588
1,007,588
1,007,588
0
1,007,588
1,007,58801,007,5881,007,5881,007,5881,007,5881,007,5881,007,5881,007,5881,007,5881,007,6631,007,6631,019,0951,019,1261,019,3881,019,3881,019,3881,019,6021,020,0161,020,0161,020,0161,009,1471,009,1471,009,1471,009,1471,009,147630,717630,717630,717630,717485,167485,167485,167485,167393,120393,120393,120393,120327,600327,600327,600327,600234,000234,000234,000234,000234,000234,000234,000234,000234,000234,000234,000234,000180,000180,000180,000180,000120,000120,000120,00090,00090,00063,90063,900
   Retained Earnings 
11,866
6,585
12,439
34,141
44,002
48,750
60,059
66,407
81,260
94,624
111,429
128,391
150,433
156,621
178,527
202,319
232,133
240,167
269,808
305,290
344,681
354,333
392,494
375,859
422,850
435,446
546,715
539,003
597,668
638,591
698,634
682,731
752,265
794,727
864,992
937,834
1,020,068
1,075,360
1,160,674
1,246,688
1,382,108
1,432,151
1,537,721
1,647,401
1,807,710
1,906,502
1,794,241
1,929,046
2,128,009
2,508,634
2,646,536
2,759,537
2,978,144
3,085,720
3,253,512
3,395,867
3,657,872
3,782,738
3,971,427
4,028,725
4,323,096
4,482,147
4,709,576
4,321,538
5,166,271
5,166,2714,321,5384,709,5764,482,1474,323,0964,028,7253,971,4273,782,7383,657,8723,395,8673,253,5123,085,7202,978,1442,759,5372,646,5362,508,6342,128,0091,929,0461,794,2411,906,5021,807,7101,647,4011,537,7211,432,1511,382,1081,246,6881,160,6741,075,3601,020,068937,834864,992794,727752,265682,731698,634638,591597,668539,003546,715435,446422,850375,859392,494354,333344,681305,290269,808240,167232,133202,319178,527156,621150,433128,391111,42994,62481,26066,40760,05948,75044,00234,14112,4396,58511,866
   Capital Surplus 00000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000-97,71000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,352
2,352
2,352
2,352
15,094
15,094
15,094
15,094
10,951
10,951
10,951
10,951
13,103
13,103
0
13,103
13,103013,10313,10310,95110,95110,95110,95115,09415,09415,09415,0942,3522,3522,3522,3520000000000000000000000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue4,834,373
Cost of Revenue-1,268,094
Gross Profit3,566,2793,566,279
 
Operating Income (+$)
Gross Profit3,566,279
Operating Expense-3,707,537
Operating Income1,126,835-141,258
 
Operating Expense (+$)
Research Development547,749
Selling General Administrative1,728,966
Selling And Marketing Expenses-
Operating Expense3,707,5372,276,715
 
Net Interest Income (+$)
Interest Income22,052
Interest Expense-7,128
Other Finance Cost-9,122
Net Interest Income24,046
 
Pretax Income (+$)
Operating Income1,126,835
Net Interest Income24,046
Other Non-Operating Income Expenses-
Income Before Tax (EBT)1,146,5241,126,835
EBIT - interestExpense = -7,128
1,044,693
1,051,821
Interest Expense7,128
Earnings Before Interest and Taxes (EBIT)-1,153,652
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax1,146,524
Tax Provision-118,573
Net Income From Continuing Ops1,027,9511,027,951
Net Income1,044,693
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--24,046
 

Technical Analysis of Jiangsu Nhwa Pharmaceutical Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Jiangsu Nhwa Pharmaceutical Co Ltd. The general trend of Jiangsu Nhwa Pharmaceutical Co Ltd is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Jiangsu Nhwa Pharmaceutical Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Jiangsu Nhwa Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 21.66 < 21.83 < 23.70.

The bearish price targets are: 20.64 > 19.28 > 15.97.

Tweet this
Jiangsu Nhwa Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Jiangsu Nhwa Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Jiangsu Nhwa Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Jiangsu Nhwa Pharmaceutical Co Ltd. The current macd is -0.63549411.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Jiangsu Nhwa Pharmaceutical Co Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Jiangsu Nhwa Pharmaceutical Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Jiangsu Nhwa Pharmaceutical Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Jiangsu Nhwa Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartJiangsu Nhwa Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Jiangsu Nhwa Pharmaceutical Co Ltd. The current adx is 16.43.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Jiangsu Nhwa Pharmaceutical Co Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Jiangsu Nhwa Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Jiangsu Nhwa Pharmaceutical Co Ltd. The current sar is 23.57.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Jiangsu Nhwa Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Jiangsu Nhwa Pharmaceutical Co Ltd. The current rsi is 35.82. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Jiangsu Nhwa Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartJiangsu Nhwa Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Jiangsu Nhwa Pharmaceutical Co Ltd. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Jiangsu Nhwa Pharmaceutical Co Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Jiangsu Nhwa Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartJiangsu Nhwa Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Jiangsu Nhwa Pharmaceutical Co Ltd. The current cci is -125.02322816.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Jiangsu Nhwa Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartJiangsu Nhwa Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Jiangsu Nhwa Pharmaceutical Co Ltd. The current cmo is -38.13029065.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Jiangsu Nhwa Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartJiangsu Nhwa Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Jiangsu Nhwa Pharmaceutical Co Ltd. The current willr is -86.66666667.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Jiangsu Nhwa Pharmaceutical Co Ltd Daily Williams %R ChartJiangsu Nhwa Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Jiangsu Nhwa Pharmaceutical Co Ltd.

Jiangsu Nhwa Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Jiangsu Nhwa Pharmaceutical Co Ltd. The current atr is 0.83923408.

Jiangsu Nhwa Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartJiangsu Nhwa Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Jiangsu Nhwa Pharmaceutical Co Ltd. The current obv is 163,555,746.

Jiangsu Nhwa Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartJiangsu Nhwa Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Jiangsu Nhwa Pharmaceutical Co Ltd. The current mfi is 52.16.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Jiangsu Nhwa Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartJiangsu Nhwa Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Jiangsu Nhwa Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-09STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-11-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-17STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-23CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-11-24STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-06CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-03WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-05MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside

6.3. Candlestick Patterns

Jiangsu Nhwa Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Jiangsu Nhwa Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5035.815
Ma 20Greater thanMa 5022.673
Ma 50Greater thanMa 10024.032
Ma 100Greater thanMa 20025.171
OpenGreater thanClose21.700
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Jiangsu Nhwa Pharmaceutical Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Jiangsu Nhwa Pharmaceutical Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Jiangsu Nhwa Pharmaceutical Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Jiangsu Nhwa Pharmaceutical Co Ltd

I send you an email if I find something interesting about Jiangsu Nhwa Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Jiangsu Nhwa Pharmaceutical Co Ltd.

Receive notifications about Jiangsu Nhwa Pharmaceutical Co Ltd in your mailbox!